Category: Companies
Putting in Safeguards on Your Property
As the owner of your own home or business, it is up to you to ensure its integrity and safety. Along with installing burglary alarms and surveillance systems, you also…
Dr Reddy’s says 50% of US revenues to come from complex drugs by 2021
Dr Reddy’s Laboratories aims to generate 50 percent revenues in the US from injectables, topicals and other complex dosage forms by 2021, according to the presentation made by the company at 36th JP…
Top 10 wealth creator mutual fund schemes of 2018
Schemes investing in technology funds were the saviour for investors throughout 2018 even as the domestic equity market wiggled through uncertainty and multiple domestic as well as global headwinds. At…
Tata Motors to hike PV prices across models by up to Rs 40,000 from January 1
Tata Motors on Thursday said it will hike prices of its passenger vehicles across models by up to Rs 40,000 from January 1, 2019, to offset the impact of rising input…
Trouble in Walmart paradise! After Binny Bansal, Myntra CEO Ananath Narayanan quits; What Flipkart plans – 5 points
Myntra’s Chief Executive Officer (CEO) Ananth Narayanan has quit, according to a report by Mint. After Binny Bansal this is another big exit from Flipkart, or its subsidiaries. The report…
How the travel industry is tackling climate change
One of the world’s largest hotel chains has installed a cogeneration plant in midtown Manhattan in an effort to reduce its carbon footprint. Cruise lines are ridding their engine exhaust of…
3 Point Analysis | Cement Sector Q2: Price outlook weak; Focus on cost efficiencies
The cement industry is traversing through a challenging landscape and the anticipated upcycle in the sector does not seem likely in near-term. However, the continued improvement in cement volumes across…
Eight of top-10 firms gain Rs 1.69 lakh cr in m-cap; TCS, SBI shine
Eight of the 10 most valued Indian firms together added Rs 1.69 lakh crore in market capitalisation last week, led by Tata Consultancy Services (TCS) and SBI. A strong broader…
Dr Reddy’s gets 8 USFDA observations for Duvvada injectable site
Drug maker Dr Reddy’s on October 8 said it got Form 483 with 8 observations from US FDA for its injectable plant in Duvvada. “This is to inform you that…
Biocon confident of meeting $200-million revenue guidance target for biologics segment
Biosimilar launches in the US and Europe coupled with larger emerging markets contribution will help Biocon meet $200-million FY19 revenue guidance for its biologics division, the biopharmaceutical firm said on…